Burlington County Public Health Profile Report
Prostate Cancer Screening: Estimated Percent (Age-adjusted), New Jersey, 2014-2015
Burlington22.0% 95% Confidence Interval(16.9% - 28.1%)Description of the Confidence IntervalThe confidence interval indicates the range of probable true values for the level of risk in the community.
A value of "NA" (Not Available) will appear if the confidence interval was not published with the NJSHAD indicator data for this measure.
State23.9% U.S. NANA=Data not available.
Burlington Compared to State
Description of Gauge
Description of the GaugeThis graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.
Why Is This Important?Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.
How Are We Doing?In 2015, 24% of New Jersey men aged 40 and over reported that a doctor, nurse, or other health professional have talked to them about the advantages and disadvantages of the PSA test.
Healthy People Objective C-19:Increase the proportion of men who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider
U.S. Target: 15.9 percent
State Target: 24.4 percent
NoteAge-adjusted to the U.S. 2000 standard population.
Data SourcesBehavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]
Measure Description for Prostate Cancer Screening
Definition: The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Numerator: The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Denominator: The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question.